OCUP Gross Margin

The Gross Margin of Ocuphire Pharma Inc (OCUP) is 87.50%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

OCUP Gross Margin - Historical Value

Date	Value
2023-12-31	87.50%

OCUP Gross Margin - Peers Comparison

Ticker	Name	Value
GALT	Galectin Therapeutics Inc	7775.20%
RZLT	Rezolute Inc	7775.20%
SNGX	Soligenix Inc	-
VTRS	Viatris Inc	41.65%
ZTS	Zoetis Inc	70.68%
ARMP	Armata Pharmaceuticals Inc	7775.20%
CLCS	Cell Source Inc	7775.20%
FWP	Forward Pharma A/S	98.00%
ABIO	ARCA Biopharma Inc	7775.20%
CYCC	Cyclacel Pharmaceuticals Inc	40.66%
ONVO	Organovo Holdings Inc	85.00%
EDT.TO	Spectral Medical Inc	44.53%
LLY	Eli Lilly and Co	81.31%
YECO	Yulong Eco-Materials Ltd	19.94%
APM	Aptorum Group Ltd	2.45%
BBI	Brickell Biotech Inc	56.79%
BMY	Bristol-Myers Squibb Co	75.26%
RPRX	Royalty Pharma PLC	7775.20%
SBM.V	Sirona Biochem Corp	92.56%
AIM	AIM ImmunoTech Inc	79.21%
ELAN	Elanco Animal Health Inc	54.88%
MBRX	Moleculin Biotech Inc	7775.20%
MRK	Merck & Co Inc	80.85%
MYMX	Mymetics Corp	-40.19%
PHIO	Phio Pharmaceuticals Corp	7775.20%
JNJ	Johnson & Johnson	69.11%
PMCB	PharmaCyte Biotech Inc	-
SBFM	Sunshine Biopharma Inc	30.60%
BIOC	Biocept Inc	-9.99%
CTLT	Catalent Inc	21.75%
IPIX	Innovation Pharmaceuticals Inc	100.00%
CAPR	Capricor Therapeutics Inc	7775.20%
CLRB	Cellectar Biosciences Inc	7775.20%
CYTH	Cyclo Therapeutics Inc	90.85%
OGEN	Oragenics Inc	60.64%
PFE	Pfizer Inc	74.19%